|
SH3D19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.878840E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.625000E-03 |
| Normal-vs-Stage2 |
5.401600E-02 |
| Normal-vs-Stage3 |
1.857370E-03 |
| Normal-vs-Stage4 |
2.062200E-02 |
| Stage1-vs-Stage2 |
9.955600E-01 |
| Stage1-vs-Stage3 |
3.408200E-01 |
| Stage1-vs-Stage4 |
8.215200E-01 |
| Stage2-vs-Stage3 |
5.401200E-01 |
| Stage2-vs-Stage4 |
8.710600E-01 |
| Stage3-vs-Stage4 |
6.409400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.721800E-03 |
| Normal-vs-AfricanAmerican |
9.764300E-02 |
| Normal-vs-Asian |
1.675580E-02 |
| Caucasian-vs-AfricanAmerican |
8.121800E-01 |
| Caucasian-vs-Asian |
8.337600E-01 |
| AfricanAmerican-vs-Asian |
7.074600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.155700E-02 |
| Normal-vs-Female |
6.383500E-04 |
| Male-vs-Female |
2.127200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.276300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.009930E-02 |
| Normal-vs-Age(61-80Yrs) |
1.336560E-03 |
| Normal-vs-Age(81-100Yrs) |
4.078000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.785200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.814400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.285200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.992800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.004400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.787000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.036000E-01 |
| Classical-VS-Follicular |
1.970210E-01 |
| Classical-VS-Other |
4.830600E-01 |
| Classical-VS-Normal |
1.617810E-02 |
| Tall-VS-Follicular |
7.600400E-01 |
| Tall-VS-Other |
5.981000E-01 |
| Tall-VS-Normal |
2.633700E-02 |
| Follicular-VS-Other |
7.851600E-01 |
| Follicular-VS-Normal |
4.058600E-03 |
| Other-VS-Normal |
1.272550E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.479640E-03 |
| Normal-vs-N1 |
4.184900E-03 |
| N0-vs-N1 |
7.399600E-01 |
|
|
